VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
Gross Profit
VIVA Biotech Holdings
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Gross Profit
¥738.4m
|
CAGR 3-Years
34%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Gross Profit
¥15.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Gross Profit
¥3.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Gross Profit
¥6.8B
|
CAGR 3-Years
39%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Gross Profit
¥2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
32%
|
|
Genscript Biotech Corp
HKEX:1548
|
Gross Profit
$409.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Gross Profit?
Gross Profit
738.4m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Gross Profit amounts to 738.4m CNY.
What is VIVA Biotech Holdings's Gross Profit growth rate?
Gross Profit CAGR 5Y
48%
Over the last year, the Gross Profit growth was -9%. The average annual Gross Profit growth rates for VIVA Biotech Holdings have been 34% over the past three years , 48% over the past five years .